Inhibition of CDK9 as a therapeutic strategy for inflammatory arthritis

Annelie Hellvard, Lutz Zeitlmann, Ulrich Heiser, Astrid Kehlen, André Niestroj, Hans-Ulrich Demuth, Joanna Koziel, Nicolas Delaleu, Jan Potempa, Piotr Mydel

Open source

DOI
10.1038/srep31441
Published
2016-08-11
Container
Scientific Reports
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/srep31441,
  title = {Inhibition of CDK9 as a therapeutic strategy for inflammatory arthritis},
  author = {Annelie Hellvard and Lutz Zeitlmann and Ulrich Heiser and Astrid Kehlen and André Niestroj and Hans-Ulrich Demuth and Joanna Koziel and Nicolas Delaleu and Jan Potempa and Piotr Mydel},
  year = {2016},
  journal = {Scientific Reports},
  doi = {10.1038/srep31441},
  url = {https://doi.org/10.1038/srep31441}
}

RIS

TY  - JOUR
TI  - Inhibition of CDK9 as a therapeutic strategy for inflammatory arthritis
AU  - Annelie Hellvard
AU  - Lutz Zeitlmann
AU  - Ulrich Heiser
AU  - Astrid Kehlen
AU  - André Niestroj
AU  - Hans-Ulrich Demuth
AU  - Joanna Koziel
AU  - Nicolas Delaleu
AU  - Jan Potempa
AU  - Piotr Mydel
PY  - 2016
JO  - Scientific Reports
DO  - 10.1038/srep31441
UR  - https://doi.org/10.1038/srep31441
ER  - 

APA

Hellvard, A., Zeitlmann, L., Heiser, U., Kehlen, A., Niestroj, A., Demuth, H., Koziel, J., Delaleu, N., Potempa, J., & Mydel, P. (2016). Inhibition of CDK9 as a therapeutic strategy for inflammatory arthritis. Scientific Reports. https://doi.org/10.1038/srep31441

Source records